Hyperprothrombinemia

From WikiMD's WELLNESSPEDIA


Hyperprothrombinemia
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Increased risk of thrombosis
Complications Deep vein thrombosis, pulmonary embolism
Onset
Duration
Types N/A
Causes Genetic mutation, liver disease, vitamin K excess
Risks Family history, liver disease, vitamin K supplementation
Diagnosis Blood test for prothrombin levels
Differential diagnosis Hypercoagulability, Factor V Leiden, Antiphospholipid syndrome
Prevention
Treatment Anticoagulant therapy
Medication Warfarin, Heparin
Prognosis Variable, depending on underlying cause and management
Frequency Rare
Deaths N/A


Hyperprothrombinemia is a medical condition characterized by an abnormally high level of prothrombin, a protein in the blood that aids in blood clotting. This condition can lead to an increased risk of thrombosis, or blood clots.

Causes[edit]

Hyperprothrombinemia can be caused by a variety of factors, including genetic mutations, certain medications, and liver disease. The most common genetic mutation associated with this condition is the G20210A mutation in the prothrombin gene.

Symptoms[edit]

The primary symptom of hyperprothrombinemia is an increased risk of developing blood clots. These clots can lead to serious health complications, such as deep vein thrombosis, pulmonary embolism, and stroke. Other symptoms can include bruising, bleeding, and pain in the affected area.

Diagnosis[edit]

Hyperprothrombinemia is typically diagnosed through a blood test that measures the level of prothrombin in the blood. Genetic testing may also be performed to identify any mutations in the prothrombin gene.

Treatment[edit]

Treatment for hyperprothrombinemia typically involves managing the risk of blood clots. This can include the use of anticoagulant medications, lifestyle changes, and in some cases, surgical procedures.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.